AU3651199A - Synthetic glycoamines and methods for their use, alone or in combination with other therapies, that affect cell adhesion, inhibit cancer cell growth and metastasis, and induce apoptosis - Google Patents

Synthetic glycoamines and methods for their use, alone or in combination with other therapies, that affect cell adhesion, inhibit cancer cell growth and metastasis, and induce apoptosis

Info

Publication number
AU3651199A
AU3651199A AU36511/99A AU3651199A AU3651199A AU 3651199 A AU3651199 A AU 3651199A AU 36511/99 A AU36511/99 A AU 36511/99A AU 3651199 A AU3651199 A AU 3651199A AU 3651199 A AU3651199 A AU 3651199A
Authority
AU
Australia
Prior art keywords
metastasis
therapies
alone
methods
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36511/99A
Other languages
English (en)
Inventor
Guennadi V. Glinskii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3651199A publication Critical patent/AU3651199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU36511/99A 1998-04-22 1999-04-22 Synthetic glycoamines and methods for their use, alone or in combination with other therapies, that affect cell adhesion, inhibit cancer cell growth and metastasis, and induce apoptosis Abandoned AU3651199A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6456898A 1998-04-22 1998-04-22
US09064568 1998-04-22
US19592198A 1998-11-19 1998-11-19
US09195921 1998-11-19
PCT/US1999/008481 WO1999053930A1 (fr) 1998-04-22 1999-04-22 Glycoamines synthetiques et leurs procedes d'utilisation, seules ou combinees a d'autres therapies, servant a influencer l'adhesion cellulaire, a inhiber la croissance et la metastase de cellules cancereuses et a provoquer l'apoptose

Publications (1)

Publication Number Publication Date
AU3651199A true AU3651199A (en) 1999-11-08

Family

ID=26744650

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36511/99A Abandoned AU3651199A (en) 1998-04-22 1999-04-22 Synthetic glycoamines and methods for their use, alone or in combination with other therapies, that affect cell adhesion, inhibit cancer cell growth and metastasis, and induce apoptosis

Country Status (2)

Country Link
AU (1) AU3651199A (fr)
WO (1) WO1999053930A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100593393B1 (ko) * 1999-01-20 2006-06-28 다카라 바이오 가부시키가이샤 치료제
CN106366139A (zh) * 2016-08-29 2017-02-01 江苏苏博特新材料股份有限公司 一种氨基酮糖类有机钢筋阻锈剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5864024A (en) * 1994-07-11 1999-01-26 Glinskii; Guennadi Victor Synthetic glycoamines and methods for their use that affect cell adhesion, inhibit cancer cell metastasis, and induce apoptosis
US5629412A (en) * 1994-07-11 1997-05-13 Glinskii; Guennadi V. Synthetic glycoamines that promote or inhibit cell adhesion

Also Published As

Publication number Publication date
WO1999053930A1 (fr) 1999-10-28

Similar Documents

Publication Publication Date Title
AU3447499A (en) An equalizer for use in multicarrier modulation systems
ZA9810688B (en) Polymeric foam substrate and its use as in combination with decorative surfaces.
AU7472798A (en) Cox-2 inhibitors in combination with nmda-blockers for treating pain
AU6813000A (en) Composition comprising micronutrients in combination with prebiotics, probiotics, and/or synbiotics
AU3716499A (en) Substituted diamines and their use as cell adhesion inhibitors
GB9913889D0 (en) Superabrasive cutter with arcuate table-to-substrate interfaces
AU4524899A (en) Materials and methods relating to the induction of apoptosis in target cells
AU1398899A (en) Cox-2 inhibitors in combination with centrally acting analgesics
AU3651199A (en) Synthetic glycoamines and methods for their use, alone or in combination with other therapies, that affect cell adhesion, inhibit cancer cell growth and metastasis, and induce apoptosis
AU7410298A (en) Synthetic glycoamines, methods for their use that affect cell adhesion, inhibit cancer cell metastasis and induce apoptosis
AU4961399A (en) Systems and methods for implementing abr with guaranteed mcr
AU5875799A (en) Mip-1alpha isoform ld78beta and uses thereof
GB2343290B (en) Disk cartridge and cartridge system equipped with the disk cartridge
AU5617199A (en) Thermostable (in vitro) complex with polymerase activity
ZA991998B (en) Absorbent articles comprising liquid distribution materials with improved distribution properties under sub-saturation conditions.
AU2752299A (en) A storage with compartments that can be opened selectively
AUPP399298A0 (en) Methods of limiting the double layer effects in electrochemical systems
AU2002217911A1 (en) Basal cell carcinoma cultures, methods related thereto and their use
GB2379697B (en) Superabrasive cutter with arcuate table-to-substrate interfaces
AU5775798A (en) Beta-galactosidase with reversibly inactive lactase activity
ZA994205B (en) Catalyst based on molibden and its use in the isomerization of n-paraffins.
AUPP642798A0 (en) Improvements in water distribution
AU7137498A (en) Dna fragmentation factor involved in apoptosis
AU5764399A (en) Antigen-presenting cells and their use in therapy
AU4922400A (en) Means and methods for altering the functional properties in eukaryotic cells

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase